Wolverine Asset Management LLC Omeros Corp Put Options Transaction History

Wolverine Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 09, 2022	SELL	$5.67 - $8.54 $221,697 - $333,913	-39,100 Reduced 22.38%	135,600 $871,000
Q3 2021 Nov 12, 2021	BUY	$13.4 - $16.3 $1 Million - $1.22 Million	74,700 Added 74.7%	174,700 $2.41 Million
Q2 2021 Aug 13, 2021	BUY	$14.81 - $19.13 $1.48 Million - $1.91 Million	100,000 New	100,000 $1.48 Million
Q1 2020 May 13, 2020	SELL	$9.03 - $19.72 $639,324 - $1.4 Million	-70,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.01 - $17.15 $534,711 - $704,864	41,100 Added 138.38%	70,800 $997,000
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $160,050 - $226,160	11,000 Added 58.82%	29,700 $485,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $261,000 - $341,388	17,400 Added 1338.46%	18,700 $293,000
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $13,936 - $21,749	1,300 New	1,300 $14,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.